BMC Bioinformatics

Table 6 The number of common drugs and JI score for early- and late-stage using the enrichment score (ES) and cMap p-value (less than 0.1) for meta-analysis

From: Drug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theory

	Effect size	ES < 0 & p _MA -value <0.1		ES < 0 & cMap p-value < 0.1
Effect size		Early-stage	Late-stage	Early-stage	Late-stage
ES < 0 & p _MA -value <0.1	Early-stage		0.557	0.078	0.152
ES < 0 & p _MA -value <0.1	Late-stage	39		0.074	0.194
ES < 0 & cMap p-value < 0.1	Early-stage	5	4		0.143
ES < 0 & cMap p-value < 0.1	Late-stage	12	13	5

Back to article page

ISSN: 1471-2105

Contact us

General enquiries: journalsubmissions@springernature.com